Infection-related stillbirths

Robert L Goldenberg, Elizabeth M McClure, Sarah Saleem, Uma M Reddy, Robert L Goldenberg, Elizabeth M McClure, Sarah Saleem, Uma M Reddy

Abstract

Infection is an important cause of stillbirths worldwide: in low-income and middle-income countries, 50% of stillbirths or more are probably caused by infection. By contrast, in high-income countries only 10-25% of stillbirths are caused by infection. Syphilis, where prevalent, causes most infectious stillbirths, and is the infection most amenable to screening and treatment. Ascending bacterial infection is a common cause of stillbirths, but prevention has proven elusive. Many viral infections cause stillbirths but aside from vaccination for common childhood diseases, we do not have a clear prevention strategy. Malaria, because of its high prevalence and extensive placental damage, accounts for large numbers of stillbirths. Intermittent malarial prophylaxis and insecticide-treated bednets should decrease stillbirths. Many infections borne by animals and vectors cause stillbirths, and these types of infections occur frequently in low-income countries. Research that better defines the relation between these infections and stillbirths, and develops strategies to reduce associated adverse outcomes, should play an important part in reduction of stillbirths in low-income countries.

Copyright 2010 Elsevier Ltd. All rights reserved.

Figures

Figure 1
Figure 1
Histological chorioamnionitis in stillborn babies by gestational age Reproduced from Lahra and colleagues, with permission from Elsevier.
Figure 2
Figure 2
Global distribution of infection with Plasmodium falciparum malaria Reproduced from Hay and Snow, and licensed to the Malaria Atlas Project (http://www.map.ox.ac.uk). PfAPI=P falciparum annual parasite incidence per 1000 people per year. PfPR2–10=P falciparum parasite rate age-standardised to 2–10 years.

References

    1. Stanton C, Lawn JE, Rahman H, Wilczynska-Ketende K, Hill K. Stillbirth rates: delivering estimates in 190 countries. Lancet. 2006;367:1487–1494.
    1. Lawn J, Shibuya K, Stein C. No cry at birth: global estimates of intrapartum stillbirths and intrapartum-related neonatal deaths 2005. Bull World Health Organ. 2005;83:409–417.
    1. McClure EM, Phiri M, Goldenberg RL. Stillbirth in developing countries: a review of the literature. Int J Gynaecol Obstet. 2006;94:82–90.
    1. Rawlinson WD, Hall B, Jones CA. Viruses and other infections in stillbirth: what is the evidence and what should we be doing? Pathology. 2008;40:149–160.
    1. Gibbs RS. The origins of stillbirth: infectious diseases. Semin Perinatol. 2002;26:75–78.
    1. Goldenberg RL, Thompson C. The infectious origin of stillbirth. Am J Obstet Gynecol. 2003;189:861–873.
    1. Di Mario S, Say L, Lincetto O. Risk factors for stillbirth in developing countries: a systematic review of the literature. Sex Transm Dis. 2007;34(suppl):S11–S21.
    1. Fretts R. Etiology and prevention of stillbirths. Am J Obstet Gynecol. 2005;193:1923–1935.
    1. Cnattingius S, Stephansson O. The epidemiology of stillbirth. Semin Perinatol. 2002;26:25–30.
    1. Copper RL, Goldenberg RL, DuBard MB, Davis RO. Risk factors for fetal death in white, black, and Hispanic women. Obstet Gynecol. 1994;84:490–495.
    1. Korteweg FJ, Gordijn SJ, Timmer A, Holm JP, Ravise JM, Erwich JJHM. A placental cause of intra-uterine fetal death depends on the perinatal mortality classification system used. Placenta. 2008;29:71–80.
    1. Nuovo GJ, Cooper LD, Bartholomew D. Histologic, infectious, and molecular correlates of idiopathic spontaneous abortion and perinatal mortality. Diagn Mol Pathol. 2005;14:152–158.
    1. Hardy JB, Azarowicz EN, Mannini A, Medaris DN, Jr, Cooke RE. The effect of Asian influenza on the outcome of pregnancy, Baltimore, 1957–1958. Am J Public Health Nations Health. 1961;51:1182–1188.
    1. Horn P. Poliomyelitis in pregnancy: a twenty-year report from Los Angeles County, California. Obstet Gynecol. 1955;6:121–137.
    1. Schwarz NG, Adegnika AA, Breitling LP. Placental malaria increases malaria risk in the first 30 months of life. Clin Infect Dis. 2008;47:1017–1025.
    1. Blanc W. Pathways of fetal and early neonatal infection. J Pediatr. 1961;59:473–496.
    1. Cooper LZ, Alford CA. Rubella. In: Remington JS, Klein JO, Baker C, Wilson CB, editors. Infectious diseases of the fetus and newborn infant. WB Saunders; Philadelphia, PA: 2006. pp. 893–926.
    1. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med. 2000;342:1500–1507.
    1. Niklasson B, Samsioe A, Papadogiannakis N. Association of zoonotic Ljungan virus with intrauterine fetal deaths. Birth Defects Res A Clin Mol Teratol. 2007;79:488–493.
    1. Martin C, Fermeauz V, Eyraud JL, Aubard Y. Streptococcus porcinus as a cause of spontaneous preterm human stillbirth. J Clin Microbiol. 2004;42:4396–4398.
    1. Lumbiganon P, Piaggio G, Villar J. The epidemiology of syphilis in pregnancy. Int J STD AIDS. 2002;13:486–494.
    1. Genc M, Ledger WJ. Syphilis in pregnancy. Sex Transm Infect. 2000;76:73–79.
    1. Congenital syphilis—United States, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:573–577.
    1. Folgosa E, Osman NB, Gonzalez C, Hagerstrand I, Bergstrom S, Ljungh A. Syphilis seroprevalence among pregnant women and its role as a risk factor for stillbirth in Maputo, Mozambique. Genitourin Med. 1996;72:339–342.
    1. Potter D, Goldenberg RL, Read JS. Correlates of syphilis seroreactivity among pregnant women: The HIVNET 024 trial in Malawi, Tanzania and Zambia. Sex Transm Dis. 2006;33:604–609.
    1. Schmid GP, Stoner BP, Hawkes S, Broutet N. The need and plan for global elimination of congenital syphilis. Sex Transm Dis. 2007;34(suppl):S5–S10.
    1. Schmid GP. Economic and programmatic aspects of congenital syphilis elimination. Bull World Health Organ. 2004;82:402–409.
    1. Sheffield JS, Sanchez PJ, Wendel GD. Placental histopathology of congenital syphilis. Obstet Gynecol. 2002;100:126–133.
    1. Watson-Jones D, Changalucha J, Gumadoka B. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis. 2002;186:940–947.
    1. Salakhov E, Tikhonova L, Southwick K, Shakarishvili A, Ryan C, Hillis C. Congenital syphilis in Russia: the value of counting epidemiologic cases and clinical cases. Sex Transm Dis. 2004;31:127–132.
    1. Sethi S, Sharma K, Dhaliwal LK, Banga SS, Sharma M. Declining trends in syphilis prevalence among antenatal women in northern India: a 10-year analysis from a tertiary healthcare centre. Sex Transm Infect. 2007;83:592.
    1. Vásquez-Manzanilla O, Dickson-Gonzalez SM, Salas JG, Rodriguez-Morales AJ, Arria M. Congenital syphilis in Valera, Venezuela. J Trop Pediatr. 2007;53:274–277.
    1. Watson-Jones D, Weiss HA, Changalucha JM. Adverse birth outcomes in United Republic of Tanzania—impact and prevention of maternal risk factors. Bull World Health Organ. 2007;85:9–17.
    1. Chi BH, Wang L, Read JS. Stillbirth in sub-Saharan Africa. Obstet Gynecol. 2007;110:989–997.
    1. Rydzak CE, Goldie SJ. Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan Africa. Sex Transm Dis. 2008;35:775–784.
    1. Hossain M, Broutet N, Hawkes S. The elimination of congenital syphilis: a comparison of the proposed World Health Organization Action Plan for the elimination of congenital syphilis with existing national maternal and congenital syphilis policies. Sex Transm Dis. 2007;34:S22–S30.
    1. MacDonald A, Benach J, Burgdorfer W. Stillbirth following maternal Lyme disease. N Y State J Med. 1987;87:615–616.
    1. Strobino BA, Williams CL, Abid S, Chalson R, Spierling P. Lyme disease and pregnancy outcome: a prospective study of two thousand prenatal patients. Am J Obstet Gynecol. 1993;169:367–374.
    1. Mhalu FS, Matre R. Serological evidence of Lyme borreliosis in Africa: results from studies in Dar Es Salaam, Tanzania. East Afr Med J. 1996;73:583–585.
    1. Melkert PW. Relapsing fever in pregnancy: analysis of high-risk factors. Br J Obstet Gynaecol. 1988;95:1070–1072.
    1. Dupont HT, La Scola B, Williams R, Raoult D. A focus of tick-borne relapsing fever in southern Zaire. Clin Infect Dis. 1997;25:139–144.
    1. McConnell J. Tick-borne relapsing fever under-reported. Lancet Infect Dis. 2003;3:604.
    1. Jongen VH, van Roosmalen J, Tiems J, Van Holten J, Wetsteyn JC. Tick-borne relapsing fever and pregnancy outcome in rural Tanzania. Acta Obstet Gynecol Scand. 1997;76:834–838.
    1. Smith B, Kemp M, Ethelberg S. Listeria monocytogenes: maternal-foetal infections in Denmark 1994–2005. Scand J Infect Dis. 2009;41:21–25.
    1. Jana N, Vasishta K, Jindal SK, Khunnu B, Ghosh K. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int J Gynaecol Obstet. 1994;44:119–124.
    1. Pillay T, Sturm AW, Khan M. Vertical transmission of Mycobacterium tuberculosis in KwaZulu Natal: impact of HIV-1 co-infection. Int J Tuberc Lung Dis. 2004;8:59–69.
    1. Madan E, Meyer MP, Amortequi A. Chorioamnionitis: a study of organisms isolated in perinatal autopsies. Ann Clin Lab Sci. 1988;18:39–45.
    1. Blackwell S, Romero R, Chaiworapongsa T. Maternal and fetal inflammatory responses in unexplained fetal death. J Matern Fetal Neonatal Med. 2003;14:151–157.
    1. Romero R, Gomez R, Ghezzi F. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol. 1998;179:186–193.
    1. Lahra MM, Gordon A, Jeffery HE. Chorioamnionitis and fetal response in stillbirth. Am J Obstet Gynecol. 2007;196:e1–e4.
    1. Folgosa E, Gonzalez C, Osman NB, Hagerstrand I, Bergstrom S, Ljungh A. A case control study of chorioamniotic infection and histological chorioamnionitis in stillbirth. APMIS. 1997;105:329–336.
    1. Tolockiene E, Morsing E, Holst E. Intrauterine infection may be a major cause of stillbirth in Sweden. Acta Obstet Gynecol Scand. 2001;80:511–518.
    1. Moyo SR, Hagerstrand I, Nystrom L. Stillbirths and intrauterine infection, histologic chorioamnionitis and microbiological findings. Int J Gynaecol Obstet. 1996;54:115–123.
    1. Moyo SR, Tswana SA, Nystrom L, Bergstrom S, Blomberg J, Ljungh A. Intrauterine death and infections during pregnancy. Int J Gynaecol Obstet. 1995;51:211–218.
    1. Axemo P, Ching C, Machungo F, Osman NB, Bergstrom S. Intrauterine infections and their association with stillbirth and preterm birth in Maputo, Mozambique. Gynecol Obstet Invest. 1993;35:108–113.
    1. Naeye RL, Tafari N, Judge D, Gilmour D, Marboe C. Amniotic fluid infections in an African city. J Pediatr. 1977;90:965–970.
    1. Goldenberg RL, Mudenda V, Read JS, for the HPTN 024 Study Team HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population. Am J Obstet Gynecol. 2006;195:1065–1074.
    1. Lamont R. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth. BJOG. 2003;110:71–75.
    1. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2003;2 CD001058.
    1. Tuomala RE, Shapiro DE, Mofenson LM. Antiretrival therapy during pregnancy and the risk of an adverse outcome. N Engl J Med. 2002;346:1863–1870.
    1. Olagbuji BN, Ezeanochie MC, Ande AB, Oboro VO. Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria. Arch Gynecol Obstet. 2009 published online July 24.
    1. Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105:836–848.
    1. Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis. 2006;193:1195–1201.
    1. Cutts FT, Robertson SE, Diaz-Ortega JL, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, 1: burden of disease from CRS. Bull World Health Organ. 1997;75:55–68.
    1. Gershon AA. Chickenpox, measles and mumps. In: Remington JS, Klein JO, Baker C, Wilson CB, editors. Infectious diseases of fetus and newborn infant. WB Saunders; Philadelphia, PA: 2006. pp. 693–738.
    1. Ornoy A, Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol. 2006;21:446–457.
    1. Gregg NM. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust. 1941;3:35–46.
    1. Dayan GH, Zimmerman L, Shteinke L. Investigation of a rubella outbreak in Kyrgyzstan in 2001: implications for an integrated approach to measles elimination and prevention of congenital rubella syndrome. J Infect Dis. 2003;187(suppl 1):S235–S240.
    1. Aaby P, Lisse IM, Bukh J, Seim E, de Silva MC. Increased perinatal mortality among children of mothers exposed to measles during pregnancy. Lancet. 1988;331:516–519.
    1. Stanwell-Smith R, Parker AM, Chakraverty P, Soltanpoor N, Simpson CN. Possible association of influenza A with fetal loss: investigation of a cluster of spontaneous abortions and stillbirths. Commun Dis Rep CDR Rev. 1994;4:R28–R32.
    1. Ng WF, Wong SF, Lam A. The placentas of patients with severe acute respiratory syndrome: a pathophysiological evaluation. Pathology. 2006;38:210–218.
    1. Jamieson DJ, Honein MA, Rasmussen SA, the Novel Influenza A (H1N1) Pregnancy Working Group H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451–458.
    1. ACOG Committee on Obstetric Practice ACOG committee opinion number 305, November 2004. Influenza vaccination and treatment during pregnancy. Obstet Gynecol. 2004;104:1125–1126.
    1. Riipinen A, Väisänen E, Nuutila M. Parvovirus b19 infection in fetal deaths. Clin Infect Dis. 2008;47:1519–1525.
    1. Public Health Laboratory Service Working Party on Fifth Disease Prospective study of human parvovirus (B19) infection in pregnancy. BMJ. 1990;300:1166–1170.
    1. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol. 1998;105:174–178.
    1. Tolfvenstam T, Papadogiannakis N, Norbeck O, Petersson K, Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet. 2001;357:1494–1497.
    1. Enders M, Weidner A, Zoellner I, Searle K, Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: a prospective evaluation of 1018 cases. Prenat Diagn. 2004;24:513–518.
    1. Wright C, Hinchliffe SA, Taylor C. Fetal pathology in intrauterine death due to parvovirus B19 infection. Br J Obstet Gynaecol. 1996;103:133–136.
    1. Kinney JS, Anderson LT, Farrar J, Strikas RA, Kumar ML, Kliegman RM. Risk of adverse outcomes after parvovirus B19 infection. J Infect Dis. 1988;157:663–667.
    1. Frisk G, Diderholm H. Increased frequency of Coxsackie B virus IgM in women with spontaneous abortion. J Infect. 1992;24:141–145.
    1. Maruyama Y, Sameshima H, Kamitomo M. Fetal manifestations and poor outcomes of congenital cytomegalovirus infections: possible candidates for intrauterine antiviral treatments. J Obstet Gynaecol Res. 2007;33:619–623.
    1. Tongsong T, Sukpan K, Wanapirak C, Phadungkiatwattna P. Fetal cytomegalovirus infection associated with cerebral hemorrhage, hydrops fetalis, and echogenic bowel: case report. Fetal Diagn Ther. 2008;23:169–172.
    1. Howard J, Hall B, Brennan LE. Utility of newborn screening cards for detecting CMV infection in cases of stillbirth. J Clin Virol. 2009;44:215–218.
    1. Syridou G, Spanakis N, Konstantinidou A. Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathological findings. J Med Virol. 2008;80:1776–1782.
    1. Ahmed RE, Karsany MS, Adam I. Brief report: acute viral hepatitis and poor maternal and perinatal outcomes in pregnant Sudanese women. J Med Virol. 2008;80:1747–1748.
    1. Hay SI, Guerra CA, Gething PW. A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med. 2009;6:e1000048.
    1. Skeketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med. 2001;64:28–35.
    1. Desai M, Oter Kuile F, Nosten F. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7:93–104.
    1. McGregor IA, Wilson ME, Billewicz WZ. Malaria infection of the placenta in The Gambia, West Africa: its incidence and relationship to stillbirth, birth weight, and placenta weight. Trans R Soc Trop Med Hyg. 1983;77:232–244.
    1. Dorman EK, Shulman CE, Kingdom J. Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria. Ultrasound Obstet Gynecol. 2002;19:165–170.
    1. Van Geertruyden JP, Thomas F, Erhart A, D'Alessandro U. The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg. 2004;71(suppl):35–40.
    1. Newman RD, Hailemariam A, Jimma D. Burden of malaria during pregnancy in areas of stable and unstable transmission in Ethiopia during a non-epidemic year. J Infect Dis. 2003;187:1765–1772.
    1. Oladapo OT, Adekanle DA, Durajaiye BO. Maternal risk factors associated with fetal death during antenatal care in low-resource tertiary hospitals. Aust NZJ Obstet Gynaecol. 2007;47:383–388.
    1. Kumar A, Valecha N, Jain T, Dash AP. Burden of malaria in India: retrospective and prospective view. Am J Trop Med Hyg. 2007;77:69–78.
    1. Coll O, Menedez C, Botet F, Dayal R, WAPM Perinatal Infections Working Group Treatment and prevention of malaria in pregnancy and newborn. J Perinat Med. 2008;36:15–29.
    1. Okie S. A new attack on malaria. N Engl J Med. 2008;358:2425–2428.
    1. Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R. Congenital toxoplasmosis: a review. Obstet Gynecol Surv. 2001;56:296–305.
    1. Onadeko MO, Joynson DH, Payne RA, Francis J. The prevalence of toxoplasma antibodies in pregnant Nigerian women and the occurrence of stillbirth and congenital malformation. Afr J Med Med Sci. 1996;25:331–334.
    1. Nimri L, Pelloux H, Elkhatib L. Detection of Toxoplasma gondii DNA and specific antibodies in high-risk pregnant women. Am J Trop Med Hyg. 2004;71:831–835.
    1. Lingam S, Marshall WC, Wilson J, Gould JM, Reinhardt MC, Evans DA. Congenital trypanosomiasis in a child born in London. Dev Med Child Neurol. 1985;27:664–674.
    1. Buekens P, Almendares O, Carlier Y. Mother-to-child transmission of Chagas' disease in North America: why don't we do more? Matern Child Health J. 2008;12:283–286.
    1. de Silva NR, Sirisena JLGJ, Gunasekera DPS, Ismail MM, de Silva HJ. Effect of mebendazole therapy during pregnancy on birth outcome. Lancet. 1999;353:1145–1149.
    1. Okun N, Gronau KA, Hannah ME. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol. 2005;105:857–868.
    1. Gibbs RS, Roberts DJ. Case records of the Massachusetts General Hospital. Case 27—2007: a 30-year-old pregnant woman with intrauterine fetal death. N Engl J Med. 2007;357:918–925.
    1. Colbourn T, Asseburg C, Bojke L. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Health Technol Assess. 2007;11:1–226.
    1. DiGiulio D, Romero R, Amogan HP. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One. 2008;3:E3056.
    1. Bhutta ZA, Darmstadt GL, Hasan BS, Haws RA. Community-based interventions for improving perinatal and neonatal health outcomes in developing countries: a review of the evidence. Pediatrics. 2005;115(suppl):519–617.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する